Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

N-(arylalkyl)-N′-pyrazolyl-urea, thiourea, guanidine and cyanoguanidine compounds as TrkA kinase inhibitors

US Patent 9969694 · Granted May 15, 2018

Estimated economic value: $20,875,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinoxaline compounds as inhibitors of FGFR tyrosine kinases2025
Spray-dried dispersions, formulations, and polymorphs of (S)-5-amino-3-(4-((5-fl2025
Protein tyrosine phosphatase inhibitors2025
Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of FGFR tyrosine kin2024
Spray-dried dispersions, formulations, and polymorphs of (s)-5-amino-3-(4-((5-fl2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors2024
Fused heterocyclic compounds as RET kinase inhibitors2024
Fused heterocyclic compounds as RET kinase inhibitors2024
KRas G12D inhibitors2024
KRas G12D inhibitors2024